Scripps Research and UCSD Scientists Awarded Approximately $7.5 Million to Identify Potential Drug Candidates to Treat …

International Symposium on Nitric Oxide and Other Gaseous Neurotransmitters

Image by mars_discovery_district
Unethical not to commercialize academic research? Dr. John Wallace, biotech entrepreneur and McMaster University scientist, offers this unorthodox view as he shines a light on the emerging field of gaseous neurotransmitters — and the value of an international symposium at MaRS in Toronto, May 27-28.

www.marsdd.com/nitric-oxide-symposium

Scripps Research And UCSD Scientists Awarded Approximately .5 Million To Identify Potential Drug Candidates To Treat …
For Immediate Release The Scripps Research Institute and the University of California, San Diego, (UCSD) School of Medicine have been awarded approximately $ 7.5 million over five years to develop novel compounds that could eventually become drug candidates for the treatment of nicotine dependence, and possibly other drug addictions. Of the funds awarded, $ 5 million will go to Scripps Research …
Read more on Medical News Today

NIH grants .5 million for researchers to develop novel compounds in treating nicotine addiction
The Scripps Research Institute and the University of California, San Diego, School of Medicine have been awarded approximately $ 7.5 million over five years to develop novel compounds that could eventually become drug candidates for the treatment of nicotine dependence, and possibly other drug addictions.
Read more on News-Medical-Net

Team awarded .5 million to identify potential drug candidates to treat nicotine addiction
( Scripps Research Institute ) The Scripps Research Institute and the University of California, San Diego, (UCSD) School of Medicine have been awarded approximately $ 7.5 million over five years to develop novel compounds that could eventually become drug candidates for the treatment of nicotine dependence, and possibly other drug addictions. Of the funds awarded, $ 5 million will go to Scripps …
Read more on EurekAlert!

Subscribe to Our Feed!

Enter your email address:

Delivered by FeedBurner